Compare ADMA Biologics Inc (ADMA) vs ArcelorMittal SA (MT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs ArcelorMittal SA — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while ArcelorMittal SA trades at $74.2 (market cap $55.88B). The key difference: ArcelorMittal SA is far larger — about 25.2× ADMA Biologics Inc's market cap, and ArcelorMittal SA pays a 0.81% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | MT | |
|---|---|---|
Market Cap | $2.22B | $55.88B |
Sector | Health | Basic Materials |
52-Week High | $20.38 | $75.35 |
52-Week Low | $7.60 | $32.44 |
Enterprise Value | $2.29B | $65.45B |
Dividend Yield | — | 0.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →
